Navigation Links
Arcadia Completes New Financing; Previews Fourth Quarter Results
Date:3/27/2009

equipment and specialty pharmacy services under its proprietary DailyMed program.

DailyMed transfers a patient's prescriptions, over-the-counter medications and vitamins, and organizes them into pre-sorted packets clearly marked with the date and time they should be taken. The entire 30-day supply is delivered directly to a patient's home in a convenient dispensing box - with "peace of mind" a pharmacist has reviewed the entire medication profile for that month's supply. This consumer product is aimed at reducing medication errors, improving medication compliance and ultimately lowering the cost of care, and is available at www.DailyMedRx.com.

The Company, headquartered in Indianapolis, Indiana, has grown to 97 locations in 21 states and currently services over 50,000 homes annually through its 5,000 full and part-time associates. Arcadia HealthCare's comprehensive solutions and business strategies support the Company's overall vision of "Keeping People at Home and Healthier Longer."

The Company's annual report on Form 10-K for the year ended March 31, 2008, the quarterly report on Form 10-Q for the periods ended June 30, 2008, September 30, 2008 and December 31, 2008 and the current reports filed from time to time on Form 8-K are available on the Company's website (http://www.arcadiahealthcare.com) and the SEC website (http://www.sec.gov).

Forward Looking Statements

Any statements contained in this release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21A of the Securiti
'/>"/>

SOURCE Arcadia Resources, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Roche Completes Acquisition of Genentech
2. Phyhealth Completes Funding Transaction with AccessKey IP, Inc.
3. Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals
4. Final Patient Completes Treatment In Boehringer Ingelheims RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
5. MxSecure, Inc. Completes Custom Document Management Interface for Roanoke Neurological Associates
6. BridgePoint Medical Completes First U.S. Clinical Case Using CrossBoss and Stingray Devices in CTO Angioplasty Procedure
7. RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition
8. Biostar Pharmaceuticals, Inc. Completes 8.6-Acre Land Purchase to House New Raw Materials Processing Plant
9. Solos Endoscopy, Inc. Successfully Completes FDA Inspection
10. NDC Completes Acquisition of Phase One Medical(R) Anchoring Technology
11. Abbott Completes Acquisition of Advanced Medical Optics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Fans get a bigger thrill when on an emotional rol...v. 26 (HealthDay News) -- Call it the fear factor ...ggests that spectators -- especially those who roo...faction if it,s a closely contested match and vict...even despair. , Chew on that this Thanksgiving ...
(Date:11/26/2009)..., Research Triangle Denta...entral North Carolina, today announced the expansi...fied LUMINEER Dentist, Dr. Doug Macmillan. , ...rch Triangle Dental is pleased to announce that Dr...st, recently completed an additional advanced trai...
(Date:11/25/2009)...,, EDINA,Minn.,Nov.25/PRNewswire-USNewswire/...dentist.Butachiropractorcanalsogivepatientsthehelp...hichiswhereyourjaw(mandible)contacts/connectswithy...sassociatedwithTMJdysfunctionarepainwithchewing,cl...ausedfromTMJdysfunctionincluding:headaches,fatigue...
(Date:11/25/2009)...,, TORONTOandCALGARY,Nov.25/PRNewswire/-Sent...sonanceImaging(MRI)coilsandsoftwareandCalgaryScien...logies,haveintroducedawebversionofAegis(TM)Breast4...veinterfaceisthefirsttrulyzero-footprintWebclientb...tific,sPureWeb(TM)platformallowsforzero-footprinta...
(Date:11/25/2009)...,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNews...FDA,sCenterforDrugEvaluationandResearch,titled"ADi...,"appearsintheNov.26,2009issueofTheNewEnglandJourn...cgi-bin/prnh/20090824/FDALOGO ) ,, Inthearticle...naccesstopainmedicationforthosewhoneeditandmanagin...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3
...search Network is very near to achieving one of to...ge in the best possible health conditions.// ...nish universities of Seville, Oviedo, Saragossa, B...beings and present in many types of food – delays ...
...ev has launched a seven-day camp in this Taj Mahal...on sex and other licentious activities.// Ram...d, said he was opposed to sex education being give...vised the young to 'exercise restraint' rather tha...
... polluted river and a handful of concerned citizen...heralded World Earth Day Sunday, //by raising its ...ile ecosystem. 'We are on the brink of a cha... needs to be addressed immediately and a day such ...
...a massive immunization drive aimed at protecting m...eak. According to health experts, nearly 10% of th... Iraq's Ministry of Health is conducting the...ld Health Organization and UNICEF have got togethe...
... the US has sentenced a man to prison for conceali...to a plasma collection center at Hammond.// ...o selling blood contaminated with the HIV in Septe...a is the largest single component of blood, making...
...as combined nanotechnology and biology to enable t...rly results. Dr. Samuel is the director of the Ins...western University. He suggests that nanotechnolog...logy might achieve in regenerative medicine, paral...
Other Medicine News:Health News:High Melatonin can Help Delay Ageing 2Health News:Earth Day Celebrated With Hopes of a Greener Tomorrow 2Health News:Nanotechnology Could Treat Spinal Cord Injuries, Diabetes, and Parkinson's Disease 2
(Date:11/25/2009)...BRUNSWICK,N.J.,Nov.25/PRNewswire/--SwissrayInterna...ography( ddR )systems,announcedtodaythatitsoperati...gtermviewtowardsgrowingSwissray,smedicalimagingbra...roperty,aswellascontractsandinventory.After25years...xtleveloftechnologicaladvancementswithstableandste...
(Date:11/25/2009)...IEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(N...pingproductsforminimallydisruptivesurgicaltreatmen...ncecallonMonday,November30,2009,at5:30p.m.ET/2:30p...ativetoreimbursementfortheCompany,sproductsandwill...ionandanswersession.Thedial-innumbersare1-877-407-...
(Date:11/25/2009)...ORK,Nov.25/PRNewswire/--Reportlinker.comannouncest...ue: ,, PainManagement-GlobalTrends ,, h...t---Global-Trends.html ,, Widespreadavailabili...andtheadventofnewdrugshaveacceleratedthepaceofgrow...imbursementstructurecontinuetoshapedemandforservic...
Breaking Medicine Technology:Swissray International Announces New Ownership 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Newly Updated Pharmacy State Law Compendium Available 5335 1Newly Updated Pharmacy State Law Compendium Available 5335 2Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 1Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 2Major health care challenges persist for D C children despite high rates of health insurance coverage RAND study finds 59154 3CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 1CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 2CSI in a virtual world 3A New grant furthers NC States work in forensic science 10303 3
... - Cytogen,Corporation (NASDAQ: CYTO) today announ...shed at upcoming major medical meetings. The,data ...QUADRAMET(R),(samarium Sm-153 lexidronam injection...astatic bone disease arising from prostate,cancer ...,evaluating the outcomes of prostate cancer patien...
...-- Once-daily,dosing with Otsuka,s investigational... antagonist, was associated with improvements,in s...ailure (ADHF),in hospitalized patients receiving c...ir long-term survival versus placebo.(1) These,dat...e,international landmark trial Efficacy of Vasopre...
Other Medicine Technology:New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 2New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 3New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 4New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 2Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 3Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 4Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 5Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 6Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials 7
... Touch control panel with 3 charging wells. Availa...Blue and Cinnamon. Spring balanced refractor and s...ction for lifelong quality. Sealed hydraulic syste...ement. Chair back reclines manually to fully horiz...
...eveloped the patented HydroKeratome corneal cuttin...t and industry experts believe it will replace the...okeratome, currently used in the LASIK refractive ...Company has demonstrated that its proprietary tech...
2.5v Ophthalmoscope Set
3.5v Coaxial Ophthalmoscope Set
Medicine Products: